Dave Helsel - 31 Jan 2023 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role: SVP Global Operations and R&D
Signature: /s/ Richard C. Rosenzweig, Attorney in Fact
Issuer symbol: ANGO
Transactions as of: 31 Jan 2023
Net transactions value: -$59,997
Form type: 4
Filing time: 01 Feb 2023, 15:07:25 UTC
Previous filing: 01 Aug 2022
Next filing: 18 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANGO	Common Stock	Sale	$59,997	-4,633	-19%	$12.95	19,189	31 Jan 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.94 to $12.97, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.94 to $12.97, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1.